companydata.dkREFLAB ApS: Financial statements 2016
CVR: 15322586
REFLAB ApS (CVR 15322586) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,732,908 and a net result of DKK -1,802,778 compared with DKK -381,585 the year before. That is a decrease of 41.6% compared with the year before. Equity amounted to DKK 1,677,110. The solvency ratio was 48.8%. The company had 6 employees in the financial year.
- Gross Profit
- 1,732,908 kr.
- Profit/Loss
- -1,802,778 kr.
- Equity
- 1,677,110 kr.
- Total Assets
- 3,435,634 kr.
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 1.7 mio. | -1.8 mio. | 1.7 mio. | 6 |
| 2015 | - | 3 mio. | -382 t. | 3.5 mio. | - |
| 2014 | - | 4.6 mio. | 1.1 mio. | 3.9 mio. | - |
| 2013 | - | 3.7 mio. | 98 t. | 2.8 mio. | - |
| 2012 | - | 2.5 mio. | -65 t. | 2.7 mio. | - |
How creditworthy is REFLAB ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
REFLAB ApS has published its annual report for 2015. Gross profit came to DKK 2,968,148, and the net result was DKK -381,585.
About REFLAB ApS
REFLAB ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 1991. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named REFERENCELABORATORIET ApS. The management consists of Gert Pynt Andersen. The company is owned by R-Biopharm AG. The company has 7 employees. In 2025, the company reported a gross profit of DKK 4,582,184 and a net result of DKK -1,792,430 compared with DKK 652,577 the year before. Equity amounted to DKK -635,048.